Trials of COVID-19 drugs underway

China is happy to share the results of clinical trials on drugs to treat novel coronavirus with the rest of the world in the effort to fight against the disease, a medical expert said at a recent news conference held by the State Council Information Office.

Cao Bin, vice-president of China-Japan Friendship Hospital, said that Chinese doctors are testing the performance of lopinavir and remdesivir on patients with COVID-19, and the clinical trial on lopinavir has been finished.

Cao also said there are two trials on remdesivir underway on the Chinese mainland -- one includes mild to moderate cases and the other is aimed at severe and critical cases -- and it seems both are going on successfully.